Tag: Lynparza

Home / Lynparza

Categories

Olaparib is approved for adjuvant treatment of high-risk early breast cancer

March 2022: The Food and Drug Administration has approved olaparib (Lynparza, AstraZeneca Pharmaceuticals, LP) for the adjuvant treatment of adult patients with deleterious or suspected deleterious ge...
lynparza

Scan the code